Halozyme Therapeutics Inc. Common Stock vs Pure Storage — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.94 (market cap $12.58B), while Pure Storage trades at $153.63 (market cap $50.17B). The key difference: Pure Storage is far larger — about 4× Halozyme Therapeutics Inc. Common Stock's market cap, and Pure Storage is more actively traded (5,733,762 versus 2,179,278). Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Pure Storage for 3 Days on average.
| HALO | P | |
|---|---|---|
Market Cap | $12.58B | $50.17B |
Volume | 2,179,278 | 5,733,762 |
Sector | Health | Technology |
52-Week High | $115.22 | $152.84 |
52-Week Low | $61.63 | $56.99 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $14.49B | $49.39B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Pure Storage develops enterprise data storage and data management systems, primarily using all-flash technology. Its platform supports cloud, AI, analytics, and mission-critical application workloads.
Read more on P →